REPL
#2597
Replimune Group, Inc. - Common Stock
9.8 7 USD
-0.01%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.70%
Variación mensual
+12.03%
Variación en los últimos 6 meses
+28.85%
Cambio anual
-13.95%
Cierres anteriores
9.9 4
Open
9.8 7
Mínimo
9.8 7
High
9.8 7
Volumen
79
Financials
- Market Capitalization 828.54 M
- Employee 465
- Founded 2015
- CEO N/A
- Website www.replimune.com
- Headquarter Delaware, United States
- FIGI BBG00L8Z22R1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.26
Relación precio/flujo de caja
753.66
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2571 |  DSGN Design Therapeutics, Inc. - Common Stock | 13.67 USD | -1.37% | -6.88% | +23.26% | +243.47% | 853.79 M USD | ||
| 2573 |  IVA Inventiva S.A. - American Depository Shares | 4.40 USD | +2.33% | +3.04% | +14.29% | +31.74% | 850.24 M USD | ||
| 2621 |  CTMX CytomX Therapeutics, Inc. - Common Stock | 3.66 USD | -1.08% | -2.92% | +20.00% | +54.43% | 796.79 M USD | ||
| 2632 |  ZVRA Zevra Therapeutics, Inc. - Common Stock | 13.06 USD | -0.91% | -8.67% | +1.95% | +22.74% | 772.04 M USD |